← Back to all trials
Recruiting
NCT07529418
The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
Conditions: Prostate Cancer
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 800
Sponsor: Institute of Cancer Research, United Kingdom
Location: The Erasmus MC Rotterdam Arnhem
Summary
The BALANCE study is a prospective Patient Reported Outcomes Measures (PROMs) study developed to look at the quality of life (QoL) of patients diagnosed with prostate cancer (PCa) in communities underrepresented in research, especially Black men of African, and Caribbean ancestry as well as men of Mixed ethnicity. This study will also investigate various PCa treatment types and their mental health impact on patients. There is a lack of research on PROMs in diverse populations. Collecting PROMs specifically from Black men and individuals with prostates who are receiving/have received treatment for PCa is essential for understanding their unique post-treatment experiences. The insights are vital to addressing documented disparities, tailoring supportive care and ultimately providing equitable health outcomes.
Participants in this study will be asked to complete a questionnaire (either electronically or hardcopy) to share their insights following their PCa diagnosis.
Eligibility Criteria
Inclusion Criteria:
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
* Age ≥ 18 years;
* Be of either:
* Black African ancestry; OR
* Black African-Caribbean ancestry; OR
* Mixed Black ancestry.
* Diagnosed with PCa;
* Assigned male at birth;
* Participants with access to digital devices (smartphones, tablets, computers) or able to complete hardcopy versions of the survey;
* Participants willing to participate and provide informed consent.
Exclusion Criteria:
A potential subject who meets any of the following criteria will be excluded from participation in this study:
* Participants having no diagnosis of PCa;
* Participants unable to provide consent;
* Participants assigned female at birth.
Source: ClinicalTrials.gov (NCT07529418). StuddyBuddy aggregates publicly available trial information.